These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2511818)

  • 61. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
    Thom J; Ivey L; Gilmore G; Eikelboom JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
    Sato K; Kagami K; Asai M; Nakashima N; Takamatsu J
    Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Screening method of lupus anticoagulants using coagulation technics: clinical application to patients with SLE and habitual abortion].
    Motoi S; Suehisa E; Nishimura K; Amino N; Miyai K; Mori M; Tanizawa O
    Rinsho Byori; 1988 Jan; 36(1):71-6. PubMed ID: 3130514
    [No Abstract]   [Full Text] [Related]  

  • 65. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
    Rosner E; Pauzner R; Lusky A; Modan M; Many A
    Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
    Magdelaine A; Verdy E
    Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Practical Considerations and Testing Nuances for the Detection of Lupus Anticoagulant: Do Low Phospholipid Screen Results, Assay Type, and Test Ratio Matter?
    Asakrah S; Davis R; Bhargava P
    Am J Clin Pathol; 2021 Nov; 156(6):1073-1082. PubMed ID: 34075395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP; Yen Y; Kriz NS; Breitenstein MG
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V; Biasiolo A; Pegoraro C; Iliceto S
    J Thromb Haemost; 2004 May; 2(5):702-7. PubMed ID: 15099274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
    Onda H; Watanabe H
    Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
    Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
    Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin.
    Liestøl S; Jacobsen EM; Wisløff F
    Thromb Res; 2002 Jan; 105(2):177-82. PubMed ID: 11958810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A study on evaluation of circulating anticoagulant in borderline cases].
    Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lupus anticoagulant testing: performance and practices by north american clinical laboratories.
    Dembitzer FR; Ledford Kraemer MR; Meijer P; Peerschke EI
    Am J Clin Pathol; 2010 Nov; 134(5):764-73. PubMed ID: 20959659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.
    Góralczyk T; Iwaniec T; Wypasek E; Undas A
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):473-5. PubMed ID: 25402189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist.
    Parmar K; Lefkou E; Doughty H; Connor P; Hunt BJ
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):271-5. PubMed ID: 19530340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.